Cargando…

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model

Background: LL-37 is the only human antimicrobial peptide that belongs to the cathelicidins. The aim of the study was to evaluate the efficacy of LL-37 in the management of MRSA-infected surgical wounds in mice. Methods: A wound on the back of adult male BALB/c mice was made and inoculated with Stap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simonetti, Oriana, Cirioni, Oscar, Goteri, Gaia, Lucarini, Guendalina, Kamysz, Elżbieta, Kamysz, Wojciech, Orlando, Fiorenza, Rizzetto, Giulio, Molinelli, Elisa, Morroni, Gianluca, Ghiselli, Roberto, Provinciali, Mauro, Giacometti, Andrea, Offidani, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532939/ https://www.ncbi.nlm.nih.gov/pubmed/34680791 http://dx.doi.org/10.3390/antibiotics10101210

Ejemplares similares

MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma
por: Lucarini, Guendalina, et al.
Publicado: (2022)

New Perspectives on Old and New Therapies of Staphylococcal Skin Infections: The Role of Biofilm Targeting in Wound Healing
por: Simonetti, Oriana, et al.
Publicado: (2021)

Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
por: Simonetti, Oriana, et al.
Publicado: (2021)

Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
por: Morroni, Gianluca, et al.
Publicado: (2021)

Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound
por: Simonetti, Oriana, et al.
Publicado: (2016)

Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi
por: Rizzetto, Giulio, et al.
Publicado: (2022)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting
por: Simonetti, Oriana, et al.
Publicado: (2021)

Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management
por: Simonetti, Oriana, et al.
Publicado: (2022)

Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review
por: De Simoni, Edoardo, et al.
Publicado: (2022)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
por: Tokajuk, Joanna, et al.
Publicado: (2022)

The Efficacy of the Quorum Sensing Inhibitor FS8 and Tigecycline in Preventing Prosthesis Biofilm in an Animal Model of Staphylococcal Infection
por: Simonetti, Oriana, et al.
Publicado: (2013)

Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review
por: Rizzetto, Giulio, et al.
Publicado: (2023)

In Vitro Activity of Novel Lipopeptides against Triazole-Resistant Aspergillus fumigatus
por: Fioriti, Simona, et al.
Publicado: (2022)

Lipidated Analogs of the LL-37-Derived Peptide Fragment KR12—Structural Analysis, Surface-Active Properties and Antimicrobial Activity
por: Kamysz, Elżbieta, et al.
Publicado: (2020)

Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult Patients
por: Radi, Giulia, et al.
Publicado: (2021)

Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives
por: Diotallevi, Federico, et al.
Publicado: (2022)

Influence of Lipidation Pattern of the KR12 Fragment of Peptide LL-37 on Its Antibacterial and Hemolytic Activities
por: Kamysz, Elżbieta, et al.
Publicado: (2023)

The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues
por: De Simoni, Edoardo, et al.
Publicado: (2023)

Pulmonary defense and the human cathelicidin hCAP-18/LL-37
por: Fahy, R. J., et al.
Publicado: (2005)

Oxidative Stress and Alterations of Paraoxonases in Atopic Dermatitis
por: Simonetti, Oriana, et al.
Publicado: (2021)

Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review
por: Marani, Andrea, et al.
Publicado: (2022)

Sneddon-Wilkinson Disease and Monoclonal Gammopathy of Undetermined Significance in the Elderly: Case Report
por: Ceccarelli, Gabriele, et al.
Publicado: (2019)

Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
por: Reinholz, Markus, et al.
Publicado: (2012)

Transformation of Human Cathelicidin LL-37 into Selective, Stable, and Potent Antimicrobial Compounds
por: Wang, Guangshun, et al.
Publicado: (2014)

Upregulation of human β-defensin-3 and cathelicidin LL-37 in Kaposi’s sarcoma
por: Fathy, Hanan, et al.
Publicado: (2012)

The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs
por: Kuroda, Kengo, et al.
Publicado: (2015)

Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans
por: Guo, Yi-jie, et al.
Publicado: (2016)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
por: Babikir, Ibrahim H., et al.
Publicado: (2018)

Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
por: Khurshid, Zohaib, et al.
Publicado: (2017)

Cathelicidin LL37 Promotes Osteogenic Differentiation in vitro and Bone Regeneration in vivo
por: Li, Lunhao, et al.
Publicado: (2021)

New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2023)

The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
por: Currie, Silke M., et al.
Publicado: (2013)

Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
por: Majewski, Karol, et al.
Publicado: (2018)

Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia
por: Podaza, Enrique, et al.
Publicado: (2020)

Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus
por: Moreno-Angarita, Alejandro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cp8qid0nb0mduogreqqucfvsk8